Shanghai OE Biotech Co., Ltd.
PrivateLast Round
M&A
Aug 30, 2025
Est. Valuation
$181.5M
Total Funding Raised
$15.5M
Company Overview
Shanghai OE Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A Extension round in November 2021.
Shanghai OE Biotech Co., Ltd. is a biotechnology company that provides multi-omics technology services, including gene sequencing, transcriptomics, proteomics, and metabolomics, to universities, hospitals, and research institutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai OE Biotech Co., Ltd. Comparables
Compare Shanghai OE Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Personal Biotechnology Co., Ltd. | 90% | |
| Novogene Co. Ltd. | 83% | |
| Annoroad Gene Technology | 82% |
For institutional investors. Book with your work email.
Shanghai OE Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 30, 2025 | ||||
| Series A Extension | Nov 3, 2021 | ||||
| Series A | Aug 1, 2021 | ||||
| Angel | Sep 1, 2020 |
For institutional investors. Book with your work email.
Shanghai OE Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 武汉鼎石汇泽投资管理有限公司 | Series A Extension |
| 健壹资本 | Series A Extension |
| Orient Securities Capital Investment Company | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2025
Closed at $181.5M post-money valuation.
- Nov 3, 2021
$16M round led by J-One Capital.
For institutional investors. Book with your work email.
Shanghai OE Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai OE Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai OE Biotech Co., Ltd. a public or private company?
Shanghai OE Biotech Co., Ltd. is a private company.
What is the current stock price of Shanghai OE Biotech Co., Ltd.?
Shanghai OE Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai OE Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai OE Biotech Co., Ltd. worth (valuation)?
Shanghai OE Biotech Co., Ltd.'s valuation is estimated at $181.5M based on funding round data.
Can I buy Shanghai OE Biotech Co., Ltd. stock?
Shanghai OE Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai OE Biotech Co., Ltd.'s last funding round?
Shanghai OE Biotech Co., Ltd.'s most recent funding round was M&A on August 30, 2025.
Who are the main investors in Shanghai OE Biotech Co., Ltd.?
Key investors in Shanghai OE Biotech Co., Ltd. include 健壹资本, Orient Securities Capital Investment Company.
Will Shanghai OE Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai OE Biotech Co., Ltd..
How can I track Shanghai OE Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai OE Biotech Co., Ltd.'s shares on secondary markets.